Skip to main content
. Author manuscript; available in PMC: 2022 Jul 5.
Published in final edited form as: Cancer. 2021 Oct 22;128(5):984–994. doi: 10.1002/cncr.33986

TABLE 2.

Abstinence Rates and Paired Comparisons for the 7-, 30-, and 90-Day Point Prevalence

Point-Prevalence Period Assessment Point UC LDC P OR (95% CI)

Full sample
 7 d 6 mo 11.3% 21.7% <.001 2.18 (1.54–3.08)
12 mo 17.0% 28.4% <.001 1.93 (1.45–2.58)
18 mo 20.7% 29.3% .001 1.59 (1.20–2.09)
24 mo 24.3% 33.1% .002 1.54 (1.18–2.02)
 30 d 6 mo 6.5% 15.3% <.001 2.58 (1.67–3.98)
12 mo 11.1% 21.3% <.001 2.18 (1.48–3.20)
18 mo 14.5% 20.9% .009 1.57 (1.12–2.19)
24 mo 18.6% 25.8% .009 1.52 (1.11–2.09)
 90 d 6 mo 4.1% 10.2% <.001 2.65 (1.57–4.49)
12 mo 8.5% 17.7% <.001 2.31 (1.52–3.53)
18 mo 11.0% 18.3% .001 1.82 (1.28–2.59)
24 mo 15.3% 22.1% .007 1.58 (1.13–2.20)
Men only
 7 d 6 mo 8.5% 20.2% <.001 2.72 (1.64–4.52)
12 mo 15.7% 29.7% <.001 2.28 (1.50–3.47)
18 mo 17.9% 32.5% <.001 2.20 (1.46–3.32)
24 mo 21.8% 35.9% <.001 2.02 (1.36–2.98)
 30 d 6 mo 4.4% 13.7% <.001 3.45 (1.78–6.69)
12 mo 10.8% 23.1% <.001 2.48 (1.47–4.18)
18 mo 13.0% 21.8% .015 1.87 (1.13–3.09)
24 mo 16.9% 28.6% .005 1.97 (1.24–3.14)
 90 d 6 mo 2.5% 8.3% .007 3.58 (1.41–9.06)
12 mo 8.1% 19.5% <.001 2.77 (1.55–4.93)
18 mo 9.7% 18.9% .004 2.17 (1.28–3.66)
24 mo 13.8% 22.7% .012 1.84 (1.14–2.95)
Women only
 7 d 6 mo 14.3% 23.3% .015 1.83 (1.15–2.91)
12 mo 18.4% 26.9% .017 1.63 (1.09–2.44)
18 mo 23.7% 25.9% .580 1.13 (0.74–1.72)
24 mo 27.0% 30.2% .420 1.17 (0.80–1.70)
 30 d 6 mo 8.8% 16.9% .009 2.12 (1.21–3.70)
12 mo 11.4% 19.5% .015 1.89 (1.13–3.15)
18 mo 16.0% 19.9% .243 1.30 (0.83–2.04)
24 mo 20.3% 22.8% .495 1.15 (0.76–1.75)
 90 d 6 mo 5.8% 12.1% .011 2.25 (1.20–4.20)
12 mo 6.1% 15.8% .029 1.90 (1.07–3.38)
18 mo 12.3% 17.6% .089 1.52 (0.94–2.47)
24 mo 16.8% 21.4% .169 1.35 (0.88–2.08)

Abbreviations: CI, confidence interval; LDC, Libre del Cigarrillo; OR, odds ratio; UC, usual care.

OR and P values for each outcome and each assessment were derived from logistic regression for LDC versus UC with the relevant 20 imputed data sets. See Appendix 3 in the supporting information for a comparable table of percent abstinent and test results for 1) responders only and 2) missing follow-up smoking status imputed as smoking.